National eczema association awards seal of acceptance to sonoma pharmaceuticals for reliefacyn advanced

Boulder, co / accesswire / august 15, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced that reliefacyn® advanced itch-burn-rash-pain relief hydrogel has received the national eczema association (nea) seal of acceptance™. reliefacyn advanced is a direct-to-consumer product available for over-the-counter use.
SNOA Ratings Summary
SNOA Quant Ranking